home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

XOMA Royalty Corporation - Common Stock (NQ:XOMA)

27.99 +1.40 (+5.27%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about XOMA Royalty Corporation - Common Stock

< Previous 1 2 3 4 5 Next >

Stocks That Hit 52-Week Lows On Monday ↗

August 28, 2023

During Monday, 102 stocks hit new 52-week lows.

Via Benzinga

XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy

August 08, 2023

From XOMA Corporation

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

July 27, 2023

During Thursday, 56 stocks hit new 52-week lows.

Via Benzinga

XOMA's Return On Capital Employed Insights ↗

May 24, 2023

Via Benzinga

XOMA Earnings Perspective: Return On Capital Employed ↗

March 15, 2023

Via Benzinga

XOMA's Return On Capital Employed Insights ↗

November 24, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

XOMA Added to the Russell 2000® and Russell 3000® Indexes

June 23, 2023

From XOMA Corporation

Via GlobeNewswire

Starbucks And 3 Other Stock Insiders Are Buying ↗

September 19, 2022

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Recap: XOMA Q4 Earnings ↗

March 08, 2022

XOMA (NASDAQ:XOMA) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA...

Via Benzinga

Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst ↗

June 22, 2023

Earlier today, XOMA Corporation (NASDAQ: XOMA) acquired the royalty and milestone rights associated with two assets from LadRx Corporation: arimoclomol for Niemann-Pick disease type C, and...

Via Benzinga

XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset

June 22, 2023

New Drug Application for arimoclomol in NPC to be filed as early as the third quarter of 2023¹

From XOMA Corporation

Via GlobeNewswire

XOMA Declares Quarterly Preferred Stock Dividends

June 20, 2023

From XOMA Corporation

Via GlobeNewswire

Recap: XOMA Q1 Earnings ↗

May 09, 2023

XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,...

Via Benzinga

XOMA: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy

May 09, 2023

From XOMA Corporation

Via GlobeNewswire

XOMA to Present at H.C. Wainwright BioConnect Investor Conference

April 26, 2023

From XOMA Corporation

Via GlobeNewswire

XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio

March 30, 2023

Acquired IXINITY® commercial payment and milestone economics from Aptevo Therapeutics

From XOMA Corporation

Via GlobeNewswire

XOMA Declares Quarterly Preferred Stock Dividends

March 21, 2023

From XOMA Corporation

Via GlobeNewswire

XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy

March 09, 2023

From XOMA Corporation

Via GlobeNewswire

XOMA to Present at 43rd Annual Cowen Health Care Conference

February 28, 2023

From XOMA Corporation

Via GlobeNewswire

XOMA: Q3 Earnings Insights ↗

November 03, 2022

XOMA (NASDAQ:XOMA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:45 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 08, 2022

On Thursday, 168 companies reached new 52-week lows.

Via Benzinga

XOMA Earnings Perspective: Return On Capital Employed ↗

May 27, 2022

Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q1 sales of $3.11 million. Earnings fell to a loss of $2.28 million, resulting in a 107.64% decrease from last quarter. In Q4, XOMA earned $29.84 million,...

Via Benzinga

XOMA's Return On Capital Employed Insights ↗

March 10, 2022

According to Benzinga Pro, during Q4, XOMA (NASDAQ:XOMA) earned $29.84 million, a 772.77% increase from the preceding quarter. XOMA also posted a total of $35.94 million in sales...

Via Benzinga

50 Biggest Movers From Yesterday ↗

January 06, 2022

Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 05, 2022

Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...

Via Benzinga

XOMA's Return On Capital Employed Overview ↗

November 08, 2021

Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q3 sales of $940.00 thousand. Earnings fell to a loss of $3.35 million, resulting in a 9.17% decrease from last quarter. In Q2,...

Via Benzinga

XOMA's Return On Capital Employed Overview ↗

September 08, 2021

According to Benzinga Pro data, during Q2, XOMA (NASDAQ:XOMA) posted sales of $901.00 thousand. Earnings were up 52.33%, but XOMA still reported an overall loss of $3.06 million....

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com